Clinical Trial: Study of the Efficacy and Safety of Maribavir for Cytomegalovirus (CMV) Infection Following Hematopoietic Stem Cell Transplantation in Children and Adolescents (China)

Posted On: 2026-09-28

China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study of the Efficacy and Safety of Maribavir for Cytomegalovirus (CMV) Infection Following Hematopoietic Stem Cell Transplantation in Children and Adolescents'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133417

Registration Time: 2026/09/26

Type: Interventional study

Primary Sponsor: Children's Hospital of Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342410

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study of the Efficacy and Safety of Maribavir for Cytomegalovirus (CMV) Infection Following Hematopoietic Stem Cell Transplantation in Children and Adolescents (China)